Artiva Biotherapeutics Inc. (ARTV) - Cash per Share

Corporate emblem and logo of Artiva Biotherapeutics Inc. (ARTV)

Cash per share for Artiva Biotherapeutics, Inc. (ARTV) demonstrates the patent protection of allogeneic NK therapies, where the current figure is 6.49. Business resilience is based on grants and partnerships with pharma behemoths. Growth is underpinned by a staff of elite geneticists supported by modern R&D funding to combat oncology. The liquidity dynamics on this chart allow for a real-time assessment of the company's financial strength during the clinical trial period.

Artiva Biotherapeutics, Inc. (ARTV) - Cash per Share from 07/20/2024 to 11/22/2026

Analytical breakdowns for Artiva Biotherapeutics, Inc.

General company analysis:Artiva Biotherapeutics, ARTV
Manufactured product of Artiva Biotherapeutics

The assessment of Artiva Biotherapeutics, Inc. (ARTV) resilience to market downturns is based on an analysis of its liquidity reserve. Developing scalable cancer cell therapy requires colossal capital expenditures in infrastructure. The current liquidity level per share reflects the net cash balance divided by the number of securities. This metric eliminates market noise, demonstrating the real value of assets. The stability of this indicator confirms the business's financial autonomy.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com